Kayentis finalises a funding round led by Extens

Back Published on 26/01/2015

Kayentis, a French publisher of software for clinical trials, finalised a funding round led by Extens, a PE firm dedicated to e-health, alongside Seventure Partners – a shareholder since 2007 – and several business angels.

Based in Grenoble, Kayentis publishes software solutions offering pharmaceutical laboratories better traceability for their clinical trials. Following a strategic repositioning on healthcare software led by new CEO Guillaume Juge, the company wants to strengthen its position in preparation for its international development.

« Kayentis was able to reinvent itself and we trust Guillaume Juge to continue the company’s transformation, especially at international level. »